Hereditary α-Tryptasemia and Peripheral Blood KIT D816V Mutation in Patients with Pediatric Mastocytosis
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26136023 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Olga Tockova und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatovenereology, University Medical Centre Ljubljana, 1000 Ljubljana, Slovenia. Hauptthemen laut MEDLINE: Tryptases, Proto-Oncogene Proteins c-kit, Mutation, Mastocytosis, Cutaneous. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The Slovenian Research and Innovation Agency, Slovenian Research Agency.
Abstract (Originalsprache)
Hereditary α-tryptasemia (HαT)—a genetic trait caused by increased α-tryptase-encoding typtase alpha/beta-1 (TPSAB1) copy number—is associated with adult mastocytosis. The primary objective was to assess the association between α-tryptase and pediatric mastocytosis. We also want to evaluate whether the KIT p.D816V mutation in peripheral blood leukocytes (PBLs) reliably predicts systemic mastocytosis (SM) in children. A prospective cohort of 68 children from a referral center in Slovenia with cutaneous mastocytosis (CM) underwent tryptase genotyping by droplet digital PCR and examination for KIT p.D816V in PBL using a sensitive PCR test. A significant majority of patients (57 of 68; [83.8%]) had at least one α-tryptase-encoding gene; none had HαT. 7 of the 68 (10.3%) who were positive for KIT p.D816V in PBL, one fulfilled diagnostic criteria for indolent SM, and another was diagnosed with monoclonal mast cell activation syndrome. One of those individuals had an increased basal serum tryptase (BST) level (14.5 ng/mL). We found a high presence of germline α-tryptase in children with CM, but not HαT. By employing sensitive examination for KIT p.D816V in PBL, in combination with clinical data and other examinations, our study suggests that KIT p.D816V in PBL may indicate systemic disease in children with CM.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Dermatovenereology, University Medical Centre Ljubljana, 1000 Ljubljana, Slovenia.
- Children's Hospital, Department of Hematology and Oncology, University Medical Center Ljubljana, 1000 Ljubljana, Slovenia.
- Laboratory for Clinical Immunology & Molecular Genetics, University Clinic of Respiratory and Allergic Diseases, 4204 Golnik, Slovenia.
- Biotechnical Faculty, University of Ljubljana, 1000 Ljubljana, Slovenia.
- Faculty of Pharmacy, University of Ljubljana, 1000 Ljubljana, Slovenia.
ORCID-Profile: Urska Bidovec Stojkovic, Matija Rijavec
Förderung
- The Slovenian Research and Innovation Agency
- Slovenian Research Agency
Zitieren
APA
Tockova, O., Planinsek Rucigaj, T., Ivancan, S., Bidovec Stojkovic, U., Rijavec, M., Šelb, J., & Korošec, P. (2025). Hereditary α-Tryptasemia and Peripheral Blood KIT D816V Mutation in Patients with Pediatric Mastocytosis. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26136023
Vancouver
Tockova O, Planinsek Rucigaj T, Ivancan S, Bidovec Stojkovic U, Rijavec M, Šelb J, et al. Hereditary α-Tryptasemia and Peripheral Blood KIT D816V Mutation in Patients with Pediatric Mastocytosis. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26136023
BibTeX
@article{Tockova2025,
author = {Tockova, Olga and Planinsek Rucigaj, Tanja and Ivancan, Simona and Bidovec Stojkovic, Urska and Rijavec, Matija and Šelb, Julij and Korošec, Peter},
title = {Hereditary α-Tryptasemia and Peripheral Blood KIT D816V Mutation in Patients with Pediatric Mastocytosis},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26136023}
}
EUVIMED